Abstract
In the myocardium of many patients with symptoms of heart failure there is a decrease in beta-adrenoceptor number, accompanied by a reduction in responsiveness to beta-agonists [3,5,8,10,16]. The hypothesis that this results simply from exposure to high circulating catecholamines is in dispute. The role of beta-adrenoceptor desensitisation in the progression of heart failure and the therapeutic implications are the subject of considerable debate.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anand IS, Ferrari R, Kalra GS. Wahi PL, Poole-Wilson PA, Harris P (1989) Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamics and plasma hormones in untreated congestive heart failure. Circulation 80: 299–305
Bayliss J, Norell M, Capena-Anson R, Sutton G, Poole-Wilson PA (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57: 17–22
Bohm M, Beuckelmann D. Brown L, Feiler G, Lorenz B, Nabauer M, Kemkes B, Erdmann E (1988) Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J 9: 844–852
Bristow MR, Ginsburg R, Gilbert EM, Hershberger RE (1987) Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart. Basic Res Cardiol 82 (Suppl 2): 369–377
Bristow MR, Ginsburg R, Minobe W. Cubicciotti RS, Sageman WS, Lurie K. Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 307: 205–211
Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W (1984) Pharmacology and inotropic potential of forskolin in the human heart. J Clin Invest 74: 212–223
Brodde OE (1988) The functional importance of beta 1 and beta 2 adrenoceptor in the human heart. A symposium: Focus on heart failure — current experiences in basic research and clinical studies on dopexamine hydrochloride (Dopacard), September 12–13. 1987. Paris, France. Proceedings. Am J Cardiol 62: 10–88C
Brodde OE, Schuler S, Kretsch R, Brinkmann M, Borst HG, Hetzer R. Reidmeister JC, Warnecke H. Zerkowski HR (1986) Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta,- and beta, -adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol 8: 1235–1242
Bronfman M, Morales MN, Orellana A (1988) Diacylglycerol activation of protein kinase C is modulated by long-chain ACYL-CoA. Biochem Biophys Res Commun 152: 987–992
Brown L, Lorenz B, Erdmann E (1986) Reduced positive inotropic effects in diseased human ventricular myocardium. Cardiovasc Res 20: 516–520
Chidsey CA, Braunwald EB, Morrow AG, Mason DT (1963) Myocardial norepinephrine concentration in man; effects of reserpine and of congestive heart failure. N Engl J Med 269: 653–658
Cohn JN, Levine TB. Olivari MT, Garberg V, Lura D, Francis GS. Simon AB. Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819–823
Erne P, Lipkin D, Maseri A (1988) Impaired beta-adrenergic receptor and normal postreceptor responsiveness in congestive heart failure. Am J Cardiol 61: 1132–1134
Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C (1988) Increase of the 40,000-mol wt pertussis toxin substrate ( G-protein) in the failing human heart. J Clin Invest 82: 189–197
Feldman MD, Copelas BS, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage failure. Circulation 2: 331–339
Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR (1986) Assessment of the Badrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74: 1290–1302
Francis GS, Goldsmith SR, Ziesche SM, Cohn JN (1982) Response of norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 49: 1152–1156
Hirata Y (1988) Heterologous down-regulation of vascular atrial natriuretic peptide receptors by phorbol esters. Biochem Biophys Res Commun 152: 1097–1103
Hopwood AM, Harding SE, Harris P (1987) An antiadrenergic effect of adenosine on guinea-pig but not rabbit ventricles. Eur J Pharmacol 137: 67–75
Karliner JS, Alabaster C, Stephens H, Barnes P, Dollery C (1981) Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. Cardiovasc Res 15: 296–304
Levitt M, Spector S. Sjoerdsma A, Undenfriend S (1965) Elucidation of the rate limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Ther 148: 1–8
Mitsuhashi M, Payan DG (1988) Phorbol ester-mediated desensitization of histamine H! receptors on a cultured smooth muscle cell line. Life Sci 43: 1433–1440
Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, Kalmar P (1988) Increase in myocardial G;-proteins in heart failure. Lancet 2: 936–937
Pierpont G L, Francis GS, DeMaster EG, Olivari MT, Ring WT, Goldberg IF, Reynolds S, Cohn JN (1987) Heterologous myocardial catecholamine concentrations in patients with congestive heart failure. Am J Cardiol 60: 316–321
Reithmann C, Werdan K (1988) Homologous vs. heterologous desensitization of the adenylate cyclase system in heart cells. Eur J Pharmacol 154: 99–104
Scholz J, Schaefer B, Schmitz W, Scholz H, Steinfath M, Lohse M, Schwabe U, Puurunen J (1988) Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart. J Pharmacol Exp Ther 245: 327–335
Sibley DR, Benovic JL, Caron MG, Lefkowitz RJ (1988) Phosphorylation of cell surface receptors: a mechanism for regulating signal transduction pathways. Endocr Rev 9: 38–56
Sole MJ, Helke CJ, Jacobwitz DM (1982) Increased dopamine in the failing hamster heart; transvesicular transport of dopamine limits the rate of norepinephrine synthesis. Am J Cardiol 49: 1682–1690
Tomlins B, Harding SE, Kirby MS, Poole-Wilson PA, Williams AJ (1986) Contamination of a cardiac sarcolemmal preparation with endothelial plasma membrane. Biochim Biophys Acta 856: 137–143
Turner JT, Bollinger DW, Toews ML (1988) Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist-and protein kinase C-mediated desensitization and further evidence for receptor internalization. J Pharmacol Exp Ther 247: 417–423
Vescovo G, Kirby MS, Harding SE, Wanless RB, Anand IS, Poole-Wilson PA (1987) Responses to isoprenaline and calcium in myocytes isolated from the hearts of adriamycin-treated rabbits. J Mol Cell Cardiol 19 (Suppl 3): 312 (Abstract)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Harding, S.E., Poole-Wilson, P.A. (1991). Beta-Adrenoceptors in Heart Failure: A Mechanism or a cAMP Follower?. In: Lewis, B.S., Kimchi, A. (eds) Heart Failure Mechanisms and Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58231-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-58231-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63509-0
Online ISBN: 978-3-642-58231-8
eBook Packages: Springer Book Archive